Market revenue in 2020 | USD 699.5 million |
Market revenue in 2028 | USD 1,113.6 million |
Growth rate | 6% (CAGR from 2020 to 2028) |
Largest segment | Mental health |
Fastest growing segment | CNS Cancer |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer |
Key market players worldwide | Biogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.
Mental health was the largest segment with a revenue share of 51.94% in 2020. Horizon Databook has segmented the Saudi Arabia central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.
According to a 2018 study published in the Journal of Psychology and Clinical Psychiatry, mental illnesses are highly prevalent in Saudi Arabia, predominantly in the elderly. Moreover, the country reports the prevalence of dementia at 6.4%; however.
the symptoms of the frequently occurring forms of dementia such as Alzheimer’s is often stigmatized and considered as a normal part of ageing by the affected individual’s family and therefore a majority do not seek medical treatments for the same.
As per the 2019 statistics made available by the Saudi Health Ministry, there were 130,000 cases of Alzheimer's present in the Saudi Arabia and is considered to be a major health problem. In order to raise awareness and remove stigma surrounding the Alzheimer’s disease.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia central nervous system therapeutic market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account